PMC:3567831 / 17592-18518 JSONTXT

{"project":"0_colil","denotations":[{"id":"22761504-16053960-6877","span":{"begin":919,"end":920},"obj":"16053960"},{"id":"22761504-17620519-6878","span":{"begin":922,"end":924},"obj":"17620519"},{"id":"22761504-17620519-6876","span":{"begin":713,"end":715},"obj":"17620519"},{"id":"22761504-18328859-6876","span":{"begin":713,"end":715},"obj":"18328859"},{"id":"22761504-18510487-6876","span":{"begin":713,"end":715},"obj":"18510487"}],"text":"Patients with persistent symptoms, despite optimal medical therapy, are usually considered candidates for septal reduction therapy. The surgical strategy has been often made depending on the patient's preference, physician's experience as well as some special status in a given situation. Compared with ablation, a longer period for recovery will be needed after TAESM because of thoracotomy and cardiopulmonary bypass. However, more and more experienced cardiac surgeons have reported encouraging results about TAESM during past years, which is considered the therapeutic gold standard in many prestigious cardiac centres today, even if alcohol septal ablation develops as another choice for high-risk patients [15–17]. TAESM can be performed safely with very low mortality and excellent long-term survival, which can be equivalent to general population, because the disease course of HCM has been changed thoroughly [6, 16]."}

{"project":"TEST0","denotations":[{"id":"22761504-236-242-6876","span":{"begin":713,"end":715},"obj":"[\"18510487\", \"17620519\", \"18328859\"]"},{"id":"22761504-198-203-6877","span":{"begin":919,"end":920},"obj":"[\"16053960\"]"},{"id":"22761504-201-207-6878","span":{"begin":922,"end":924},"obj":"[\"17620519\"]"}],"text":"Patients with persistent symptoms, despite optimal medical therapy, are usually considered candidates for septal reduction therapy. The surgical strategy has been often made depending on the patient's preference, physician's experience as well as some special status in a given situation. Compared with ablation, a longer period for recovery will be needed after TAESM because of thoracotomy and cardiopulmonary bypass. However, more and more experienced cardiac surgeons have reported encouraging results about TAESM during past years, which is considered the therapeutic gold standard in many prestigious cardiac centres today, even if alcohol septal ablation develops as another choice for high-risk patients [15–17]. TAESM can be performed safely with very low mortality and excellent long-term survival, which can be equivalent to general population, because the disease course of HCM has been changed thoroughly [6, 16]."}

{"project":"2_test","denotations":[{"id":"22761504-18510487-28905042","span":{"begin":713,"end":715},"obj":"18510487"},{"id":"22761504-17620519-28905042","span":{"begin":713,"end":715},"obj":"17620519"},{"id":"22761504-18328859-28905042","span":{"begin":713,"end":715},"obj":"18328859"},{"id":"22761504-16053960-28905043","span":{"begin":919,"end":920},"obj":"16053960"},{"id":"22761504-17620519-28905044","span":{"begin":922,"end":924},"obj":"17620519"}],"text":"Patients with persistent symptoms, despite optimal medical therapy, are usually considered candidates for septal reduction therapy. The surgical strategy has been often made depending on the patient's preference, physician's experience as well as some special status in a given situation. Compared with ablation, a longer period for recovery will be needed after TAESM because of thoracotomy and cardiopulmonary bypass. However, more and more experienced cardiac surgeons have reported encouraging results about TAESM during past years, which is considered the therapeutic gold standard in many prestigious cardiac centres today, even if alcohol septal ablation develops as another choice for high-risk patients [15–17]. TAESM can be performed safely with very low mortality and excellent long-term survival, which can be equivalent to general population, because the disease course of HCM has been changed thoroughly [6, 16]."}

{"project":"MyTest","denotations":[{"id":"22761504-18510487-28905042","span":{"begin":713,"end":715},"obj":"18510487"},{"id":"22761504-17620519-28905042","span":{"begin":713,"end":715},"obj":"17620519"},{"id":"22761504-18328859-28905042","span":{"begin":713,"end":715},"obj":"18328859"},{"id":"22761504-16053960-28905043","span":{"begin":919,"end":920},"obj":"16053960"},{"id":"22761504-17620519-28905044","span":{"begin":922,"end":924},"obj":"17620519"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"Patients with persistent symptoms, despite optimal medical therapy, are usually considered candidates for septal reduction therapy. The surgical strategy has been often made depending on the patient's preference, physician's experience as well as some special status in a given situation. Compared with ablation, a longer period for recovery will be needed after TAESM because of thoracotomy and cardiopulmonary bypass. However, more and more experienced cardiac surgeons have reported encouraging results about TAESM during past years, which is considered the therapeutic gold standard in many prestigious cardiac centres today, even if alcohol septal ablation develops as another choice for high-risk patients [15–17]. TAESM can be performed safely with very low mortality and excellent long-term survival, which can be equivalent to general population, because the disease course of HCM has been changed thoroughly [6, 16]."}